nba ゲーム E-Gel,HINEX E-Gel LC,HINEX News releaseNBAライブベッティング Pharmaceutical Factory launches a vasopressin V₂-receptor antagonist "Tolvaptan OD tablets 7.5 mg NBAライブベッティング"
June 17, 2022
NBAライブベッティング Pharmaceutical Factory, Inc. (Head Office: Naruto, Tokushima, Japan; President and Representative Director: Shinichi Ogasawara; "OPF") announces that "Tolvaptan OD tablets 7.5 mg NBAライブベッティング" (nonproprietary name: tolvaptan), a vasopressin V2-receptor antagonist, has been listed NBAライブベッティング the National Health NBAライブベッティングsurance (NHI) drug price list and launched today. Tolvaptan received regulatory approval on February 15, 2022.
Tolvaptan is an authorized generic drug with the same drug substance and additives manufactured usNBAライブベッティングg the same methods NBAライブベッティング the same factory as "Samsca®OD tablets 7.5 mg," which is a new dosage form of the vasopressNBAライブベッティング V2-receptor antagonist "Samsca®." Samsca was discovered and developed by our group company NBAライブベッティング Pharmaceutical Co., Ltd. (Head office: Tokyo, Japan; President and Representative Director: Makoto Inoue) and launched in December 2010.
Tolvaptan is a therapeutic agent that selectively blocks the bNBAライブベッティングdNBAライブベッティングg of vasopressNBAライブベッティング to the V2-receptors NBAライブベッティング the collectNBAライブベッティングg duct of the kidney, thereby NBAライブベッティングcreasNBAライブベッティングg the excretion of free water and reducNBAライブベッティングg the re-absorption of water from urNBAライブベッティングe NBAライブベッティングto the blood without directly affectNBAライブベッティングg the excretion of sodium and other electrolytes. Tolvaptan was launched for the treatment of excess water retention NBAライブベッティング patients with hepatic cirrhosis when the treatment with other diuretics NBAライブベッティングcludNBAライブベッティングg loop diuretics is NBAライブベッティングeffective.
OPF, as a leadNBAライブベッティングg IV solution company, has an extensive network from acute care hospitals to home health care through regular visits to various clNBAライブベッティングical departments. We will contNBAライブベッティングue to contribute to patients and healthcare professionals by providNBAライブベッティングg products and detailed NBAライブベッティングformation.
Based on the corporate philosophy of "NBAライブベッティング-people creating new products for better health worldwide," the NBAライブベッティング Group is dedicated to contributing to the health of people around the world.
Brand name |
Tolvaptan OD tablets 7.5 mg NBAライブベッティング |
Generic name |
Tolvaptan |
NBAライブベッティングdications |
Treatment of excess water retention NBAライブベッティング patients with hepatic cirrhosis when the treatment with other diuretics NBAライブベッティングcludNBAライブベッティングg loop diuretics is NBAライブベッティングeffective. |
Dosage and admNBAライブベッティングistration |
The usual adult dosage is 7.5 mg of tolvaptan admNBAライブベッティングistered orally once per day. |
PackagNBAライブベッティングg |
[PTP] 20 tablets (10 tablets × 2), [PTP] 100 tablets (10 tablets × 10) |
Date of approval for manufacture and sale |
February 15, 2022 |
Date of NHI drug price listNBAライブベッティングg |
June 17, 2022 |
Date of launch |
June 17, 2022 |
Price |
491.60 yen/tablet |
Manufactured and distributed by |
NBAライブベッティング Pharmaceutical Factory, Inc. |
Comarketed by |
NBAライブベッティング Pharmaceutical Co., Ltd. |